303Followers on Owler

Akcea

Read more
Damien McDevitt's photo - CEO of Akcea

CEO

Damien McDevitt

CEO Approval Rating

75/100

Est. Annual Revenue
$100-500M
Agree?
Est. Employees
250-500
Agree?
Funding
$668.2M

Akcea Competitors and Alternatives

1
3
5
7
2
4
6
8
See more competitor data

Akcea News

Akcea Press Releases

Akcea Videos

Akcea Headquarters

22 Boston Wharf Road 9th Floor

Boston, Massachusetts02210

617-207-0202

Driving Directions »

Akcea Summary

ABOUT

Overview

Akcea is a biopharmaceutical company that develops RNA-targeted antisense therapeutics for the treatment of cardiometabolic lipid disorders. Akcea was founded in 2015. Akcea's headquarters is located in Boston, Massachusetts, USA 02210. Akcea's CEO, ...

CEO

Akcea's CEO, Damien McDevitt, currently has an approval rating of 75%. Akcea's primary competitors are Alnylam, Eidos & Amryt Pharma.

Acquisitions

There have been no acquisitions found related to Akcea

Investments

Recent investment data cannot be found related to Akcea

Frequently Asked Questions about Akcea

  1. When was Akcea founded?

    Akcea was founded in 2015
  2. Who is Akcea's CEO?

    Akcea's CEO is Damien McDevitt
  3. How much revenue does Akcea generate?

    Akcea generates $489M in revenue
  4. How much funding does Akcea have?

    Akcea has historically raised $668.2M in funding
  1. Where is Akcea's headquarters?

    Akcea's headquarters is in Boston Massachusetts, USA
  2. How many employees does Akcea have?

    Akcea has 300 employees
  3. What sector does Akcea operate in?

    Akcea is in Biotechnology, Pharmaceuticals
  4. Who are Akcea's competitors?

    Akcea's top competitors are Alnylam, Eidos, Amryt Pharma

Trending Companies